EDITORIAL SYNOPSIS This is a second controlled trial of carbenoxolone sodium in the treatment of chronic gastric ulcer and confirms the beneficial experience previously reported. It is the only drug therapy for gastric ulcer which has been demonstrated conclusively to accelerate healing, which can be achieved with patients remaining up and about, often at work, and with minimum change in diet.
Many remedies have been recommended for the treatment of gastric ulcers. Few, however, have been tested in a controlled way and those that have have nearly always been found to be ineffectual. In a series of controlled trials carried out at the Central Middlesex Hospital over the last 16 years, 13 treatments have been examined and a materially beneficial effect has been observed with only three: bed rest, stopping smoking, and the administration of carbenoxolone sodium' (Doll, 1964) . This last substance is a pentacyclic triterpene prepared from the liquorice glycoside, glycyrrhizinic acid. It has an anti-inflammatory effect in animals and in some skin diseases, and produces sodium and water retention in some subjects (Doll, Hill, Hutton, and Underwood, 1962) . There is, however, no obvious reason why it should help the healing of gastric ulcers, and the possibility had to be considered that the apparently beneficial results were due to unrelated factors, even though the probability of their having occurred by chance alone was extremely low (P < 0001). The drug, moreover, can have important side-effects, so that it was undesirable to use it widely without conclusive evidence of its value. In these circumstances we felt that it was proper to withhold the drug in the initial treatment of some patients, and we, therefore, subjected it to a second controlled trial. At the same time we took advantage of this opportunity to see if the results could be improved by adding oestrogens, which Truelove (1960) had found to help in the healing of duodenal ulcers. ' Reported previously under the proprietary name Biogastrone (disodium salt).
METHOD
Patients in whom a gastric ulcer was diagnosed radiologically and who were thought suitable for out-patient treatment were referred to a special clinic. On their first attendance they were referred for a further barium meal examination and were seen again three days later. Patients were accepted into the trial only if a gastric ulcer niche was still present and was more than 10 sq. mm. in area in maximum profile. They were excluded if an ulcer or an ulcer scar was seen in the duodenum or if there was clinical or radiological suspicion of malignancy. Because of the side-effects noted previously, patients were also excluded if over 70 years old or if there was evidence of material heart disease or hypertension.
The remaining patients were divided into four groups according to their sex and age. Patients in each group were numbered serially and were given one of several treatments by reference to the serial numbers on a random list maintained in the hospital pharmacy. For men under 60 years of age, the treatments were: (1) carbenoxolone sodium, 100 mg. three times a day, and stilboestrol, 0-5 mg. twice a day; (2) carbenoxolone sodium and dummy tablets in place of the stilboestrol; (3) stilboestrol and dummy tablets in place of the carbenoxolone; and (4) two sets of dummy tablets. Men of 60 years and over were treated in the same way except that each dose of carbenoxolone sodium was reduced to 75 mg. Women over 60 years were treated like men of the same ages, save that oestriol 0 5 mg. was substituted for the stilboestrol. For women under 60 years, the oestrogen treatment and the corresponding dummy tablets were omitted.
Neither the physician (R.D.) nor the radiologist (C.F.H.) knew which treatments had been given to individual patients until after the end of the trial, except in a few instances in which the development of sideeffects made it desirable to find out.
All patients were advised to continue at possible; to take a normal diet apart from food; to eat, or drink a glass of milk, at lea hours; and to stop smoking. They were also tablets to take as necessary for the relief ofpa Patients were seen weekly and the ti continued for four weeks, unless there wa significant side-effects when the dose of c sodium was reduced or stopped. Rapid gain in weight or the development of dyspi oedema were treated by adding a daily 4 chlorthiazide 50 mg. and potassium chlorid A further barium meal examination wa five weeks and the trial period was complet later. The results were assessed by the cha the ulcer niche and the numbers of days patients complained of pain.
RESULTS
One hundred and two patients were treatment, but 56 were considered ur the trial and were excluded for th reasons. (Wilcoxon, 1945) showed that the probability of 56 obtaining so much separation of the groups by ' Ten of the patients in the first trial were given carbenoxolone acid in place of the disodium salt. chance factors alone was very small. In the first trial the probability was less than 0 001; in the second, the probability of obtaining so much separation in the same direction was 0006. If the one patient in the second trial who received the specific treatment for only three days (and whose ulcer healed by only 49 %) is omitted, the probability is even smaller (0 005).
The average number of days with pain in the second trial was twice as great in the carbenoxolone sodium series as in the controls (Table II) , but the difference is not quite statistically significant (0 1 > P > 0 05); in view of the fact that the difference was in the opposite direction in the first trial, we regard this as a chance effect.
In view of the general similarity between the results in the two trials, it is extremely difficult to believe that the greater amount of healing in the carbenoxolone sodium series can have been anything other than a direct effect of the treatment.
The results cannot be attributed to bias on the part of either the patients or the observers. The trial was, admittedly, not wholly 'double blind' because the appearance of side-effects suggested the method of treatment in half the carbenoxolone sodium series. Beneficial results were, however, not limited to this group and if the 16 patients who were suspected of showing a side-effect or who were given a diuretic because of rapid gain in weight are omitted, the results are equally striking. Among the remaining 11 patients in the carbenoxolone sodium series, the average reduction in the size of the ulcer niche was 74%; among the 19 similar patients in the control series it was 32 %.
The very minor variation in the timing of the barium meal examinations can hardly have been important. The two patients in the carbenoxolone sodium series in whom the examination was delayed will presumably have shown somewhat more healing than if they had been radiographed at the planned time; but the difference is unlikely to have affected the average rate of healing by more than 1 %. In the control patient in whom the examination was carried out too soon, the ulcer had already healed.
The comparability of the patients before the start of treatment and in the extent to which they received ancillary treatments is illustrated in Table  III . The differences between the two groups of patients are, in general, small. As in the previous trial, there was a tendency for the patients given carbenoxolone sodium to modify their smoking habits more than the patients in the control series and this could have been one factor contributing to the results. In fact, the results were closely similar to those in the first trial and changes in smoking habits seemed to make very little difference. Patients who received carbenoxolone sodium did better than the other patients in each smoking category (Table IV) , and, despite the paucity of numbers, the difference in the average reduction in ulcer size was statistically significant in one category (for men who stopped smoking, P = 0-047). 32 (9) 62 (3) 60 (5) 16 (5) Undesired side-effects were again observed in this study in a substantial proportion of cases. Five (21 %) of the 24 patients given carbenoxolone sodium developed oedema of the ankles, a proportion similar to that in the first trial (17 %). Four complained of dyspnoea, including two who developed oedema, and one patient with dyspnoea showed congestion of the veins of the neck. All seven patients had gained weight before the onset of these symptoms, the amount varying from 31 lb. (in a woman of 67 years) to 10 lb. (in a woman of 52 years), the average being 6 lb. Symptoms usually appeared during the second or third week of treatment, but one patient became dyspnoeic with slight oedema during the first week and one was free of symptoms until the fourth. Albuminuria was not detected in any patient. Regular measurements of blood pressure were not made at the beginning of the study and repeat observations are available for only three of the patients; all of these showed increases of between 10 and 25 mm. Hg systolic and 0 and 30 mm. Hg diastolic. At a later stage, blood pressure was recorded weekly in all patients and a comparison between nine patients on carbenoxolone sodium and 10 not on the drug is shown in Figure 1 .
The mean maximum increase of pressure over the pre-treatment reading was 20 mm. Hg systolic and 12 mm. Hg diastolic for the carbenoxolone sodium group, and 8 mm. systolic and 3 mm. diastolic for the control group. Glycyrrhizinic acid and extracts of liquorice have been shown to produce sodium and water retention and potassium excretion in man (Borst, ten Holt, de Vries, and Molhuysen, 1953; Salassa, Mattox, and Rosevear, 1962) and carbenoxolone sodium to produce sodium and water retention in rats (Finney and Tairnoky, 1960) , and these effects can reasonably be attributed to this 2 A. SYSTOLIC I... ... action. Tafrnoky and Hausmann (1964) (personal communication) , however, failed to find any evidence of sodium retention after two weeks' treatment with carbenoxolone sodium in man, although they did find hypokalaemia and hypertension.
Other symptoms associated with treatment are less clearly due to the drug. Headache accompanied by increase in weight was reported by two patients on carbenoxolone sodium. One had gained 9j lb. and also complained of dyspnoea: the other, who had never previously suffered from headache, had four days' moderately severe pain associated with a gain of 4 lb. in weight during the second week. Unusual temporary headache, severe enough to arouse the suspicion that it might be due to the drug, was also noted in one patient in the control series.
Heartburn, immediately after taking the tablets, was reported by one patient on carbenoxolone sodium and another patient, who had originally been on inert tablets, had it so severely when he switched to carbenoxolone sodium, after completing his course of treatment, that the tablets had to be stopped. Four out of 58 patients in the first trial complained of heartburn and it seems certain that this symptom can be produced by the drug. Other patients, in both treatment and control series, complained of mild heartburn which was less obviously related to the tablets, but it is possible that the drug was responsible for the symptoms in some instances.
One man, aged 61 years, complained of a continuous heavy pain across the chest radiating to the jaw and elbows which began in bed at night after three days' treatment with carbenoxolone sodium. He was admitted to hospital as a possible case of coronary thrombosis and the pain cleared within 24 hours. An E.C.G. suggested posterior ischaemia, OESTROGENS The data are re-examined in Table V to show the results obtained with and without the addition of stilboestrol (in men) or oestriol (in women over 60 years). When the patients who were given oestrogens are grouped together, including those who were given carbenoxolone sodium and those who were not, it is seen that they fared somewhat better than the control patients (73 % average reduction in the size of the ulcer niche compared with 570%). The numbers of cases are, however, small, the benefit is less marked than with carbenoxolone sodium, and the difference, though compatible with an appreciable effect, is not statistically significant.
Few other data on the use of oestrogens for gastric ulcer are available. In his review of the literature Truelove (1960) noted that 'Korbsch (1937) Truelove used the same dose of stilboestrol (0 5 mg. twice a day), but he gave it daily for six months and the effect on sexual activity was marked.
Diminution or loss of sexual potency was usual and gynaecomastia also occurred, the latter being of minor importance and not appearing until about the fourth or fifth month of treatment. In the present study oestrogens were given for only four weeks. None of the 13 men given stilboestrol volunteered information about loss of potency, but two complained of soreness of the breasts, in each case several weeks after the treatment had stopped. No complications were associated with the use of oestriol. Oestrogens did not seem to increase the risk of water retention associated with the use of carbenoxolone sodium; three of the nine patients given both drugs complained of oedema or dyspnoea, whereas the same symptoms were noted by four of the 15 patients given carbenoxolone sodium alone.
SUMMARY
The effects of carbenoxolone sodium and of oestrogens on the healing of gastric ulcers have been assessed in a controlled trial, in which patients were allocated to the treatment groups by a form of restricted randomization.
All patients were treated ambulantly; 24 were given carbenoxolone sodium (75 or 100 mg. three times a day) and 22 were given inert tablets. Treatment was continued for four weeks and the results were assessed by the change in size of the ulcer niche and by the number of days on which the patient complained of pain. Among the patients given the active drug, the ulcer healed completely in 10 (42 %) and, on average, the size of the niche was reduced by 78 %. Among the patients given the inert tablets the ulcer healed completely in six (270%) and, on average, the size of the niche was reduced by 39 %.
These results are similar to those of a previous trial and the probability of obtaining so much difference between the groups, in the same direction as previously, by chance factors alone, is small (P < 0 01).
Pain disappeared quickly in nearly all patients and there was no significant difference between the groups in the number of days on which pain was noted. Seven patients given carbenoxolone sodium developed ankle oedema or dyspnoea accompanied by an average gain of 6 lb. in weight. Blood pressure was commonly increased during treatment and these effects are attributed to a retention of sodium and water. Rarer side-effects included headache and heartburn.
Male patients received in addition stilboestrol, 0.5 mg., or a second set of inert tablets twice a day; women aged 60 years or over received a similar treatment save that oestriol 0.5 mg. was substituted for the stilboestrol. On average the ulcer healed by 73% in the 17 patients given oestrogens and by 57% in the 17 patients given inert tablets. This difference between the groups is not statistically significant.
It is concluded that carbenoxolone sodium facilitates the healing of gastric ulcers. Oestrogens may also have a beneficial effect but the present data are inconclusive. 
